Dongfeng Qi, a director of biostatistics and data management at Boston Scientific Corporation, won the Visionary Award at the 2019 Women of Color STEM Conference.
The award is presented to individuals whose work demonstrates the innovation that furthers research and development related to science, technology, engineering, and math (STEM) fields.
In Minnesota, she is an active member of the American Statistical Association and the China Association for Science and Technology (CAST).
Qi s also involved in formal mentoring at the Minnesota School of Public Health, and informal mentoring programs for students, which introduce biostatistics and clinical research.
Qi joined Boston Scientific in 2015 as part of the American Medical Systems (AMS) Men's Health and Prostate Health businesses acquisition.
During her time with AMS, she managed biostatistics and was responsible for biostatistics and clinical data information systems to ensure that milestones were met across AMS Women’s Health, Men’s Health, and Prostate Health business units.
Qi has a proven track record of effective interactions with the Food and Drug Administration (FDA), a federal agency of the U.S. Department of Health and Human Services.
She has presented and defended multiple investigational device exemption (IDE) and premarket approval (PMA) study designs to the FDA. She has also designed more than 500 studies for prolapse repair using the propensity score methodology.
After earning a master's degree in chemistry, she came to America to continue her education and received a Ph.D. in chemistry and another master’s degree in biostatistics.
Click here to watch Dongfeng Qi accept the 2019 WOC Stem Conference Visionary Award.
Click HERE to register for the 2021 Women of Color STEM Conference.
